Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 22, 2019

SELL
$8.02 - $13.25 $92,631 - $153,037
-11,550 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$10.04 - $13.92 $115,961 - $160,776
-11,550 Reduced 50.0%
11,550 $160,000
Q1 2019

May 01, 2019

BUY
$10.04 - $13.92 $105,921 - $146,856
10,550 Added 84.06%
23,100 $320,000
Q4 2018

Feb 13, 2019

SELL
$8.38 - $13.44 $33,520 - $53,760
-4,000 Reduced 24.17%
12,550 $123,000
Q3 2018

Nov 14, 2018

BUY
$11.6 - $16.54 $191,980 - $273,737
16,550 New
16,550 $198,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.57B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.